Tuberculosis Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

4 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Siiltibcy

    Active substance: Mycobacterium tuberculosis derived antigens (rdESAT‑6 and rCFP‑10)

    EMEA/H/C/006177
  • Dovprela (previously Pretomanid FGK)

    Active substance: pretomanid

    EMEA/H/C/005167
  • Deltyba

    Active substance: Delamanid

    EMEA/H/C/002552
  • Sirturo

    Active substance: bedaquiline fumarate

    EMEA/H/C/002614

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on tuberculosis

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.